sesquiterpenes, eudesmane

Preferred Label : sesquiterpenes, eudesmane;

MeSH definition : SESQUITERPENES cyclized into two adjoining cyclohexane rings but with a different configuration from the ARTEMISININS.;

MeSH synonym : eudesmane sesquiterpenes; Eudesmane Derivatives; Derivatives, Eudesmane; Eudesmanes;

MeSH hyponym : Furanoeudesmane Derivatives; Derivatives, Furanoeudesmane; Furanoeremophilane Derivatives; Derivatives, Furanoeremophilane;

Is substance : O;

Details

Origin ID

D045787;

UMLS CUI

C1258161;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- Furanoeremophilanes [MeSH concept]
- Furanoeudesmanes [MeSH concept]
- sesquiterpenes, eudesmane [MeSH concept]
Related MeSH Supplementary Concept(s)
- (+)-5-epi-eudesm-4(15)-ene-1beta,6beta-diol [MeSH Supplementary Concept]
- (1R,2R,5S,6S,7R,10S)*-ax-4(15)-ene-1alpha,2beta,7beta-triol [MeSH Supplementary Concept]
- (1R,2R,5S,6S,7S,10S)*-5-epi-eudesm-4(15)-ene-1alpha,2beta,6alpha-triol [MeSH Supplementary Concept]
- (4R*,5R*,7S*,10R*)-eudesm-11-en-4-ylamine hydrochloride [MeSH Supplementary Concept]
- 1,2,3,4-diepoxy-11(13)-eudesmen-12,8-olide [MeSH Supplementary Concept]
- 1,3-dihydroxyeudesman-11(13)-en-6,12-olide [MeSH Supplementary Concept]
- 1,3-dihydroxyeudesman-6,12-olide [MeSH Supplementary Concept]
- 1,4,13-trihydroxy-eudesm-11(12)-ene [MeSH Supplementary Concept]
- 1,5,6,14-tetraacetoxy-9-benzoyloxy-7H-eudesman-2,11-diol [MeSH Supplementary Concept]
- 1,6-dihydroxy-4H-1,10-secoeudesma-5(10),11(13)-dien-12,8-olide [MeSH Supplementary Concept]
- 1,6-dihydroxyeudesm-3-ene [MeSH Supplementary Concept]
- 1,8-dihydroxyeudesman-3,7(11)-dien-8,12-olide [MeSH Supplementary Concept]
- 1,9-dihydroxyeudesm-3-en-5beta,6alpha,7alpha,11alphaH-12,6-olide [MeSH Supplementary Concept]
- 1-O-beta-D-glucopyranosyl-9beta,15-dihydroxy-5alpha,6betaH-eudesma-3-ene-6alpha,12-olide [MeSH Supplementary Concept]
- 1-oxo-4aH-eudesma-5(6),11(13)-dien-12,8-olide [MeSH Supplementary Concept]
- 1-oxoeudesm-11(13)-eno-12,8-lactone [MeSH Supplementary Concept]
- 1-oxoeudesm-11(13)-eno-12,8a-lactone [MeSH Supplementary Concept]
- 11 beta H-2 alpha-hydroxy-eudesman-4(15)-en-12,8 beta-olide [MeSH Supplementary Concept]
- 11,12-O-isopropylidenesolajiangxin F [MeSH Supplementary Concept]
- 11-acetoxyeudesman-4alpha-methyl-5alpha-ol [MeSH Supplementary Concept]
- 11-hydroxy-2,4-cycloeudesman-8-one [MeSH Supplementary Concept]
- 11-hydroxy-3-oxo-6H,7H-10-methyl-eudesman-1,2-4,5-dien-6,12-olide [MeSH Supplementary Concept]
- 11-hydroxy-eudesm-5-en-8beta,12-olide [MeSH Supplementary Concept]
- 13-sulfo-dihydroreynosin [MeSH Supplementary Concept]
- 1beta,8beta-dihydroxy-eudesman-4(15),7(11)-dien-8alpha,l2-olide [MeSH Supplementary Concept]
- 1beta-(p-hydroxyphenyl acetyl)-15-O-beta-D-glucopyranosyl-5alpha, 6betaH-eudesma-3-en-12, 6alpha-olide [MeSH Supplementary Concept]
- 1beta-sulfate-5alpha,6betaH-eudesma-3-en-12,6alpha-olide [MeSH Supplementary Concept]
- 2,4-cyclo-7(11)-eudesmen-8-one [MeSH Supplementary Concept]
- 2,5-peroxy-6,11H-eudesm-3-en-6,13-olide [MeSH Supplementary Concept]
- 3-acetoxyeudesma-1,4(15),11(13)-trien-12,6-olide [MeSH Supplementary Concept]
- 3-oxo-eudesma-1,4(15),11(13)triene-12,6alpha-olide [MeSH Supplementary Concept]
- 3-oxo-gamma-costic acid [MeSH Supplementary Concept]
- 3alpha,7alpha-12-trihydroxyeudesm-4(15)-11(13)-diene [MeSH Supplementary Concept]
- 3alpha-hydroxyilicic acid [MeSH Supplementary Concept]
- 3beta,11alpha-dihydroxy-eudesm-5-en-8beta,12-olide [MeSH Supplementary Concept]
- 3beta-hydroxy-11,13-dihydroalantolactone [MeSH Supplementary Concept]
- 3beta-hydroxy-11betaH-eudesm-5-en-8beta,12-olide [MeSH Supplementary Concept]
- 4(15)-eudesmene-1,5-diol [MeSH Supplementary Concept]
- 4,11(13)-eudesmadien-12-oic acid [MeSH Supplementary Concept]
- 4,15-epoxyeudesmane-1,6-diol [MeSH Supplementary Concept]
- 4,5-diacetoxy-9-benzoyloxy-7H-eudesman-1,2,11,14-tetraol [MeSH Supplementary Concept]
- 4,5-dioxo-11-methoxy-eudesm-6-ene [MeSH Supplementary Concept]
- 4-cinnamoyloxy-1,3-dihydroxyeudesm-7,8-ene [MeSH Supplementary Concept]
- 4-hydroxyeudesmane-1,6-dione [MeSH Supplementary Concept]
- 4alpha,6alpha-epoxy-1beta-hydroxy-4beta-methyleudesmane [MeSH Supplementary Concept]
- 4alpha,7beta-dihyroxyeudesmane [MeSH Supplementary Concept]
- 4beta,7beta,11-enantioeudesmantriol [MeSH Supplementary Concept]
- 5 beta-hydroxyilicic acid [MeSH Supplementary Concept]
- 5, 6, 7,10- 11, 13-dihydro-4(15)-eudesmene-12, 6-olide [MeSH Supplementary Concept]
- 5alpha,7beta-dihydroxyeudesmane [MeSH Supplementary Concept]
- 5alpha-hydroxyl-4-epi-ilicic acid methyl ester [MeSH Supplementary Concept]
- 6-isobutyryloxy-1-hydroxy-4H-1,10-secoeudesma-5(10),11(13)-dien-12,8-olide [MeSH Supplementary Concept]
- 6-isovaleryloxy-1-hydroxy-4H-1,10-secoeudesma-5(10),11(13)-dien-12,8-olide [MeSH Supplementary Concept]
- 6alpha-acetoxy-1beta,4alpha-dihydroxy-5,7alpha H,8 beta H-eudesm-11beta,13-dihydro-8,12-olide [MeSH Supplementary Concept]
- 6alpha-acetoxy-7beta-hydroxyeudesm-4-ene [MeSH Supplementary Concept]
- 6beta,14-epoxyeudesm-4(15)-en-1beta-ol [MeSH Supplementary Concept]
- 7-(acetyloxy)-5a-((acetyloxy)methyl)octahydro-6-hydroxy- 2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepine-5,10-diyl dibenzoate [MeSH Supplementary Concept]
- 7-oxo-tri-nor-eudesm-5-en-4beta-ol [MeSH Supplementary Concept]
- 8,11-dihydroxy-2,4-cycloeudesmane [MeSH Supplementary Concept]
- 8-hydroxy-7-(1-hydroxypropan-2-yl)-1,4a-dimethyl-5,6,7,8-tetrahydronaphthalen-2(4aH)-one [MeSH Supplementary Concept]
- 8-oxo-eudesm-6-en-5alpha,11-diol [MeSH Supplementary Concept]
- 8-oxo-tri-nor-eudesm-6-en-5alpha-ol [MeSH Supplementary Concept]
- 8alpha-hydroxyeudesma-4(15),7(11)-dien-8beta,12-olide [MeSH Supplementary Concept]
- 9-hydroxyepinootkatol [MeSH Supplementary Concept]
- C13-norisoprenoid, 3alpha,6alpha-dihydroxymegastigman-7-en-9-one 3- O-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- alantolactone [MeSH Supplementary Concept]
- alpha-eudesmol [MeSH Supplementary Concept]
- arbusclin D [MeSH Supplementary Concept]
- artemisidiol A [MeSH Supplementary Concept]
- artemisidiol B [MeSH Supplementary Concept]
- artemisidiol C [MeSH Supplementary Concept]
- arundinol A [MeSH Supplementary Concept]
- arundinol B [MeSH Supplementary Concept]
- arundinol C [MeSH Supplementary Concept]
- arundinone A [MeSH Supplementary Concept]
- arundinone B [MeSH Supplementary Concept]
- axinyssamine hydrochloride, (4R*,5R*,7S*,10R*)-4-isocyanato-eudesm-11-ene [MeSH Supplementary Concept]
- beta-eudesmol [MeSH Supplementary Concept]
- beta-selinene [MeSH Supplementary Concept]
- capitulatin B [MeSH Supplementary Concept]
- carissone [MeSH Supplementary Concept]
- chlorantene A [MeSH Supplementary Concept]
- chlorantene B [MeSH Supplementary Concept]
- daucucarotol-10-O-glucopyranoside [MeSH Supplementary Concept]
- decahydro-7-((2-O-glucopyranosyl)isopropyl)-1,4a-dimethyl-(1,4,8a)-naphthalenetriol [MeSH Supplementary Concept]
- delta-4-carene [MeSH Supplementary Concept]
- dihydroreynosin [MeSH Supplementary Concept]
- ent-4(15)-eudesmen-11-ol-1-one [MeSH Supplementary Concept]
- ent-4(15)-eudesmen-1alpha,11-diol [MeSH Supplementary Concept]
- eudebeiolide D [MeSH Supplementary Concept]
- eudesma-4(15),7(11)-dien-8alpha,12-ether [MeSH Supplementary Concept]
- eudesmadiene-12,6-olide [MeSH Supplementary Concept]
- eudesmane [MeSH Supplementary Concept]
- formamidoeudesm-11-ene [MeSH Supplementary Concept]
- furanoeudesma-1,3-diene [MeSH Supplementary Concept]
- furanoeudesmane [MeSH Supplementary Concept]
- gamma-eudesmol [MeSH Supplementary Concept]
- halichonadin E [MeSH Supplementary Concept]
- halichonadin F [MeSH Supplementary Concept]
- japonicone A [MeSH Supplementary Concept]
- jatrophaeudesmene C [MeSH Supplementary Concept]
- judaicin (eudesmane naphthofuran) [MeSH Supplementary Concept]
- liriopeoside A [MeSH Supplementary Concept]
- lyratol G [MeSH Supplementary Concept]
- ophiopogonoside A [MeSH Supplementary Concept]
- ophiopogonoside B [MeSH Supplementary Concept]
- phomanolide C [MeSH Supplementary Concept]
- plebeiolide C [MeSH Supplementary Concept]
- pluchargen A [MeSH Supplementary Concept]
- pterodontriol E [MeSH Supplementary Concept]
- pterodontriol F [MeSH Supplementary Concept]
- pumilaside A [MeSH Supplementary Concept]
- rel-1,3,6-trihydroxyeudesm-4-ene [MeSH Supplementary Concept]
- salplebeone A [MeSH Supplementary Concept]
- salplebeone B [MeSH Supplementary Concept]
- salplebeone C [MeSH Supplementary Concept]
- samboginone [MeSH Supplementary Concept]
- septemlobin D [MeSH Supplementary Concept]
- sorangiadenosine [MeSH Supplementary Concept]
- tanapsin [MeSH Supplementary Concept]
- telekin [MeSH Supplementary Concept]
- tri-nor-eudesm-5-en-7beta,8beta-diol [MeSH Supplementary Concept]
- wenyujinlactone A [MeSH Supplementary Concept]
- yomogin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients